A Prospective, Non-interventional, Observational Study To Describe the Effectiveness of Trandolapril (Mavik) in the Management of Patients Requiring Angiotensin Converting Enzyme Inhibitor Treatment.
Phase of Trial: Phase IV
Latest Information Update: 10 Oct 2012
At a glance
- Drugs Trandolapril (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms in-MAU-tion
- Sponsors Abbott Laboratories
- 17 Jan 2012 Actual patient number changed from 8001 to 7993 as reported by ClinicalTrials.gov.
- 02 Dec 2011 Actual end date (Sep 2011) added as reported by ClinicalTrials.gov.
- 02 Dec 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.